Perspective Therapeutics, Inc. ('Perspective' or the 'Company') (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced ...

Prostate cancer has become a significant health concern among men, being the second leading cause of death in the United States. While the survival rate in men remains high, those who have ...

As the Trump administration upends federal research, Mizzou aims to raise more than $1 billion to build an advanced nuclear reactor to accelerate production of key ingredients for cancer treatments.

Bruce Power first began commercially producing Lutetium-177 in 2022, following the construction of an isotope production system at the plant's Unit 7 reactor, making it the world's first commercial ...

Discover Piper Sandler's latest biotech oncology picks, ratings, and price targets. Gain expert insights on CGON, BCAX, DAWN, ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Prostate Cancer companies working in the treatment market are Telix Pharmaceuticals, Merck and Orion, Exelixis, Ipsen Pharma and Takeda, Pfizer, AstraZeneca, Kangpu Biopharmaceuticals, Merus, Blue ...

In the final overall survival analysis, researchers pitted Lu-177-PSMA-617 (Pluvicto) against an ARPI in the second-line ...

Donald Trump has branded masked protesters in public demonstrations as terrorists, while the ICE brigands wear required face ...

Radioligand therapy uses radio-labeled antibodies to deliver targeted radiation directly to prostate cancer cells, minimizing damage to healthy tissue, resulting in fewer and less grueling side ...

Europe’s role as a pioneer Europe has long led in nuclear medicine, driving medical isotope production and fostering academic and clinical ecosystems that enabled breakthrough therapies like Novartis’ ...